Reframe Daily: news and a mini app for you to stay healthy
One study tested a vancomycin step-down plan to stop C. diff from coming back, another sped up feeding-tube placement in ICU patients, HIV clinics boosted quit rates with meds plus small rewards, a new inherited-high-cholesterol pill dropped LDL, and a new GLP-1 shot every 2 weeks drove weight loss in a phase 2b trial.
